A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence

Mucosal Immunology

Volumn 2, Issue 3, 2009, Pages 232-242

  Alam, M S ^a   Kurtz, C C ^a   Wilson, J M ^a   Burnette, B R ^a   Wiznerowicz, E B ^a   Ross, W G ^a   Rieger, J M ^b   Figler, R A ^b   Linden, J ^a   Crowe, S E ^a   Ernst, P B ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Adenosine Therapeutics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ATL 313; CYCLIC AMP; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 10; PIPERIDINE DERIVATIVE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GASTRITIS; HELICOBACTER PYLORI; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HELICOBACTER FELIS; HELICOBACTER INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; STOMACH MUCOSA;

ANIMALS; ANTIGENS, CD4; CYCLIC AMP; CYTOKINES; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER FELIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; PIPERIDINES; RECEPTOR, ADENOSINE A2A; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65449135161     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.4     Document Type: Article

References (42)

1. Algood, H.M. & Cover, T.L. Helicobacter pylori persistence: An overview of interactions between H. pylori and host immune defenses. Clin. Microbiol. Rev. 19, 597-613 (2006).
2. Dixon, M.F. Pathophysiology of Helicobacter pylori infection. Scand. J. Gastroenterol. 29, 7-10 (1994).
3. Hopkins, R.J., Girardi, L.S. & Turney, E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review. Gastroenterology 110, 1244-1252 (1996).
4. Ernst, P.B., Peura, D.A. & Crowe, S.E. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 130, 188-206 (2006).
5. Correa, P. & Miller, M.J.S. Carcinogenesis, apoptosis and cell proliferation. Br. Med. Bull. 54, 151-162 (1998).
6. Karttunen, R. et al. Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin. Exp. Immunol. 82 485-488 (1990).
7. D'Elios, M.M. et al. T helper 1 effector cells specific for Helicobacter pylori in gastric antrum of patients with peptic ulcer disease. J. Immunol. 158, 962-967 (1997).
8. Bamford, K.B. et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114, 482-492 (1998).
9. Ahlstedt, I. et al. Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection. Infect. Immun. 67, 4921-4925 (1999).
10. Eaton, K.A., Mefford, M. & Thevenot, T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 166, 7456-7461 (2001).
11. Lundgren, A. et al. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73, 523-531 (2005).
12. Alam, M.S. et al. CD73 is expressed by human regulatory Th cells and suppresses pro-inflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J. Infect. Dis. 199, 494-504 (2009).
13. Rad, R. et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131, 525-537 (2006).
14. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007).
15. Kobie, J.J. et al. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′ -adenosine monophosphate to adenosine. J. Immunol. 177, 6780-6786 (2006).
16. Sitkovsky, M.V. et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22, 657-682 (2004).
17. Lappas, C.M., Rieger, J.M. & Linden, J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J. Immunol. 174, 1073-1080 (2005).
18. Mabley, J. et al. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′ -N-methyluronamide, is protective in two murine models of colitis. Eur. J. Pharmacol. 466, 323-329 (2003).
19. Chaves, I.C. et al. Effect of a novel A2A adenosine receptor agonist (ATL 313) on Clostridium difficile toxin induced murine ileal enteritis. Infect. Immun. 74, 2606-2612 (2006).
20. Odashima, M. et al. Selective adenosine A receptor agonist, ATL-146e, attenuates stress-induced gastric lesions in rats. J. Gastroenterol. Hepatol. 20, 275-280 (2005).
21. Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225-1232 (2007).
22. 2A receptors in the T cell mediated regulation of colitis. J. Immunol. 177, 2765-2769 (2006).
23. Zarek, P.E. et al. A2A receptor signaling promotes peripheral tolerance by inducing T cell anergy and the generation of adaptive regulatory T cells. Blood 111, 251-259 (2008).
24. Seybold, J. et al. Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in beta2-adrenoreceptor desensitization. J. Biol. Chem. 273, 20575-20588 (1998).
25. Haeberle, H.A. et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect. Immun. 65, 4229-4235 (1997).
26. Lee, A., Fox, J.G., Otto, G. & Murphy, J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 99, 1315-1323 (1990).
27. Cai, X. et al. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 128, 1937-1952 (2005).
28. Ismail, H.F., Fick, P., Zhang, J., Lynch, R.G. & Berg, D.J. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J. Immunol. 170, 3782-3789 (2003).
29. Berg, D.J., Lynch, N.A., Lynch, R.G. & Lauricella, D.M. Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10(-/-) mice. Am. J. Pathol. 152, 1377-1386 (1998).
30. Koshiba, M., Rosin, D.L., Hayashi, N., Linden, J. & Sitkovsky, M.V. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol. Pharmacol. 55, 614-624 (1999).
31. Luzza, F. et al. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165, 5332-5337 (2000).
32. Karttunen, R., Karttunen, T., Ekre, H.-P.T. & MacDonald, T.T. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36 341-345 (1995).
33. Goll, R. et al. Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter 12, 185-192 (2007).
34. Enarsson, K. et al. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin. Immunol. 121, 358-368 (2006).
35. Stromberg, E. et al. Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors. Clin. Exp. Immunol. 140, 117-125 (2005).
36. Linden, J. New insights into the regulation of inflammation by adenosine. J. Clin. Invest. 116, 1835-1837 (2006).
37. Ismail, H.F., Zhang, J., Lynch, R.G. & Berg, D.J. Complement in clearance of H. pylori infection in IL-10 knock out mice. Infect. Immun. 71, 7140-7148 (2003).
38. Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C (T)) method. Methods 25, 402-408 (2001).
39. Thompson, L.J. et al. Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect. Immun. 72, 4668-4679 (2004).
40. 2 increases AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127, 845-858 (2004).
41. Pappo, J. et al. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67, 337-341 (1999).
42. Ismail, H.F., Zhang, J., Lynch, R.G., Wang, Y. & Berg, D.J. Role for complement in development of Helicobacter-induced gastritis in interleukin-10-deficient mice. Infect. Immun. 71, 7140-7148 (2003).